Developer docs
API playgroundTry for free, no card

Search company profiles

iSelect Fund

Full company profile

uuid00006yf

Namestring
iSelect Fund
Legal namestring
iSelect Fund
Websiteurl
iselectfund.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

iSelect Fund is a privately held, evergreen venture capital firm founded in 2014 and headquartered in St. Louis, Missouri, with team members in New York, Boston, and San Francisco. The firm invests at the intersection of food, agriculture, soil health, and human health — anchored by a 'Food is Health' thesis that frames poor nutrition as a driver of chronic disease and rising healthcare costs. iSelect targets early-stage companies in agriculture technology, cardiometabolic healthcare, and resource efficiency, and has built a portfolio of roughly 50-70+ companies representing 2,500+ combined employees.

iSelect's core offering is not a software product but a curated investment platform: accredited investors, family offices, wealth managers, and institutional clients gain access to vetted early-stage opportunities alongside tier-one venture co-investors such as Google Ventures, Andreessen Horowitz, Menlo Ventures, Y Combinator, S2G Investments, and Anterra Capital. Each investment is supported by up to 120 hours of due diligence drawn from a network of 200+ industry advisors with over 3,000 years of combined experience, including 30 PhDs, 40 startup founders, and 20 prior exits. Securities are distributed through North Capital Private Securities (Member FINRA/SIPC), which provides the regulatory and broker-dealer infrastructure for the offering.

iSelect generates returns through venture fund management — managing evergreen capital, participating in follow-on rounds via participation rights, and earning economics from successful exits. The firm has no publicly disclosed revenue, AUM, or fee schedule. It pursues thought-leadership distribution through the Crusonia Conversations podcast, the AgriFood Conversations webinar series, and CEO Carter Williams' public policy work, including 2024 U.S. Senate testimony on 'Feeding a Healthier America.' Recent strategic moves include follow-on participation in Miraterra's $16M CAD seed extension (March 2026) and an investment collaboration with The Nature Conservancy focused on soil health.

Short descriptiontext

iSelect Fund is a privately held evergreen venture capital firm that invests at the intersection of food, agriculture, soil health, and human health, offering accredited investors, family offices, wealth managers, and institutions vetted early-stage deals alongside tier-one VC co-investors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital fund, early-stage investing, agtech investment, food health thesis, impact venture investing
Industry3 codes
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSAEAAAC
Portfolio Construction & Asset Allocation Advisory
SECONDARYBPAHADAE
Due Diligence Advisory (Commercial/Financial/Operational)
NAICS code3 codes
  • Portfolio Management and Investment Advice52394
  • Other Investment Pools and Funds5259
  • Other Financial Investment Activities5239
SIC code2 codes
  • Investment Advice6282
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
Product category
Venture Capital and Impact Investing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Fund Management
TypeSubscription Recurring
Description

iSelect generates returns by investing in early-stage companies in agriculture, healthcare, and food technology sectors. The fund provides investors with access to a diversified portfolio of startups, managed investment oversight, and participation rights in follow-on funding rounds.

iselectfund.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

iSelect Fund is an evergreen venture capital fund that provides accredited investors, family offices, wealth managers, and institutional investors access to vetted early-stage investment opportunities in food, agriculture, healthcare, and resource efficiency sectors. The fund conducts up to 120 hours of due diligence per portfolio company, manages investments on behalf of investors, and offers co-investment opportunities alongside top-tier venture capital firms. Securities are offered through North Capital Private Securities, a registered broker-dealer.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

iSelect Fund is a venture capital firm structured as an evergreen fund that offers investors ongoing access to investment opportunities in the food, health, and agriculture sectors. Rather than a unified software platform, the fund provides a network model connecting entrepreneurs, investors, early adopter customers, and industry experts. Investors access the fund's portfolio companies, diligence process, and industry expertise through the fund's investor portal and network services. The fund's primary offering is its investment platform, which includes vetted portfolio companies in agriculture, food tech, and healthcare verticals.

Product and service2 records
1iSelect Fund
CategoryVenture Capital Fund
2Co-Investment Program for Family Offices
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

iSelect announced an investment collaboration with The Nature Conservancy focused on accelerating progress against ambitious soil health goals. The Nature Conservancy is a leading global conservation organization working on soil health and sustainable agriculture.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

S2G is a multi-stage venture fund investing across food, agriculture, and ocean. Direct competitor to iSelect with a similar food/health thesis, larger AUM, and an existing co-investment relationship with iSelect (joint participant in Miraterra's 2026 round).

2Anterra Capital
TypeDirect peer
Description

Anterra is a venture capital firm investing globally in food, agriculture, and animal health. Direct peer to iSelect — both target the food/agtech convergence, and Anterra is an existing co-investor alongside iSelect in portfolio companies.

TypeDirect peer
Description

Cultivian Sandbox invests in early-stage food and agriculture technology companies. Direct peer to iSelect with a comparable sector mandate and an established co-investor relationship across iSelect's portfolio.

TypeDirect peer
Description

AgFunder is a venture capital and media platform investing in agrifood technology. Direct competitor with overlapping investment themes (agtech, foodtech) and complementary media reach; both target the food/ag convergence.

TypeDirect peer
Description

Pontifax AgTech (now part of Pontifax Global Food and Agriculture Technology Fund) invests in food and agtech. Closely comparable to iSelect on stage (early/growth) and thesis (food/agriculture technology convergence).

TypeDirect peer
Description

Fall Line Capital is an early-stage venture firm focused on agricultural technology. Direct peer to iSelect in agtech investing with comparable portfolio stage and sector focus.

TypeDirect peer
Description

Breakthrough Energy Ventures (Bill Gates–backed) invests in companies tackling climate change, with significant overlap in agriculture, food, and health technologies. Comparable to iSelect on early-stage climate-adjacent food/ag investing.

TypeBroad incumbent
Description

ADM Ventures is the corporate venture arm of Archer Daniels Midland, one of the world's largest food/ag companies. Larger incumbent operating broadly in iSelect's sector and an existing co-investor in iSelect's portfolio companies (e.g., Miraterra round).

TypeBroad incumbent
Description

Khosla Ventures is a major US venture firm with significant early-stage exposure to food, agriculture, and health technology. Larger incumbent with broader portfolio but thematic overlap with iSelect's investment areas.

10Leaps by Bayer
TypeBroad incumbent
Description

Leaps by Bayer is the corporate venture arm of Bayer focused on life sciences, agriculture, and health. Strategic incumbent that competes for food/ag/health deals and brings deep corporate balance sheet capacity versus iSelect's evergreen structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment85 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iSelect Fund

Venture Capital and Impact Investingiselectfund.com

iSelect Fund is a privately held evergreen venture capital firm that invests at the intersection of food, agriculture, soil health, and human health, offering accredited investors, family offices, wealth managers, and institutions vetted early-stage deals alongside tier-one VC co-investors.

What iSelect Fund does

iSelect Fund is a privately held, evergreen venture capital firm founded in 2014 and headquartered in St. Louis, Missouri, with team members in New York, Boston, and San Francisco. The firm invests at the intersection of food, agriculture, soil health, and human health — anchored by a 'Food is Health' thesis that frames poor nutrition as a driver of chronic disease and rising healthcare costs. iSelect targets early-stage companies in agriculture technology, cardiometabolic healthcare, and resource efficiency, and has built a portfolio of roughly 50-70+ companies representing 2,500+ combined employees.

iSelect's core offering is not a software product but a curated investment platform: accredited investors, family offices, wealth managers, and institutional clients gain access to vetted early-stage opportunities alongside tier-one venture co-investors such as Google Ventures, Andreessen Horowitz, Menlo Ventures, Y Combinator, S2G Investments, and Anterra Capital. Each investment is supported by up to 120 hours of due diligence drawn from a network of 200+ industry advisors with over 3,000 years of combined experience, including 30 PhDs, 40 startup founders, and 20 prior exits. Securities are distributed through North Capital Private Securities (Member FINRA/SIPC), which provides the regulatory and broker-dealer infrastructure for the offering.

iSelect generates returns through venture fund management — managing evergreen capital, participating in follow-on rounds via participation rights, and earning economics from successful exits. The firm has no publicly disclosed revenue, AUM, or fee schedule. It pursues thought-leadership distribution through the Crusonia Conversations podcast, the AgriFood Conversations webinar series, and CEO Carter Williams' public policy work, including 2024 U.S. Senate testimony on 'Feeding a Healthier America.' Recent strategic moves include follow-on participation in Miraterra's $16M CAD seed extension (March 2026) and an investment collaboration with The Nature Conservancy focused on soil health.

iSelect Fund firmographics

Firmographics
Name
iSelect Fund
Legal name
iSelect Fund
Website
https://iselectfund.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
iSelect Fund is a privately held evergreen venture capital firm that invests at the intersection of food, agriculture, soil health, and human health, offering accredited investors, family offices, wealth managers, and institutions vetted early-stage deals alongside tier-one VC co-investors.
Ownership category
akta.pro rank

iSelect Fund industry classification

Industry
Product category
Venture Capital and Impact Investing
NAICS
Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282), Security & Commodity Brokers, Dealers, Exchanges & Services (6200)
akta.pro industry
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSAEAAAC
Portfolio Construction & Asset Allocation Advisory
SECONDARYBPAHADAE
Due Diligence Advisory (Commercial/Financial/Operational)

Keywords

  • Venture capital fund
  • Early-stage investing
  • Agtech investment
  • Food health thesis
  • Impact venture investing

Where iSelect Fund is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

iSelect Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Venture Fund Management: iSelect generates returns by investing in early-stage companies in agriculture, healthcare, and food technology sectors. The fund provides investors with access to a diversified portfolio of startups, managed investment oversight, and participation rights in follow-on funding rounds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

iSelect Fund product offering

Product offering

Core offering

iSelect Fund is an evergreen venture capital fund that provides accredited investors, family offices, wealth managers, and institutional investors access to vetted early-stage investment opportunities in food, agriculture, healthcare, and resource efficiency sectors. The fund conducts up to 120 hours of due diligence per portfolio company, manages investments on behalf of investors, and offers co-investment opportunities alongside top-tier venture capital firms. Securities are offered through North Capital Private Securities, a registered broker-dealer.

Product overview

iSelect Fund is a venture capital firm structured as an evergreen fund that offers investors ongoing access to investment opportunities in the food, health, and agriculture sectors. Rather than a unified software platform, the fund provides a network model connecting entrepreneurs, investors, early adopter customers, and industry experts. Investors access the fund's portfolio companies, diligence process, and industry expertise through the fund's investor portal and network services. The fund's primary offering is its investment platform, which includes vetted portfolio companies in agriculture, food tech, and healthcare verticals.

Differentiator

Problem solved

Functional benefit

Products and services

  • iSelect Fund
  • Co-Investment Program for Family Offices

Companies that use iSelect Fund

Customer profile

Segments4 records

Ideal customer profiles4 records

iSelect Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

iSelect Fund partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • The Nature ConservancycoreStrategic or Co-development PartneriSelect announced an investment collaboration with The Nature Conservancy focused on accelerating progress against ambitious soil health goals. The Nature Conservancy is a leading global conservation organization working on soil health and sustainable agriculture.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

iSelect Fund competitors and assessment

Company assessment

Direct peers

  • S2G Investments: S2G is a multi-stage venture fund investing across food, agriculture, and ocean. Direct competitor to iSelect with a similar food/health thesis, larger AUM, and an existing co-investment relationship with iSelect (joint participant in Miraterra's 2026 round).
  • Anterra Capital: Anterra is a venture capital firm investing globally in food, agriculture, and animal health. Direct peer to iSelect — both target the food/agtech convergence, and Anterra is an existing co-investor alongside iSelect in portfolio companies.
  • Cultivian Sandbox Ventures: Cultivian Sandbox invests in early-stage food and agriculture technology companies. Direct peer to iSelect with a comparable sector mandate and an established co-investor relationship across iSelect's portfolio.
  • AgFunder: AgFunder is a venture capital and media platform investing in agrifood technology. Direct competitor with overlapping investment themes (agtech, foodtech) and complementary media reach; both target the food/ag convergence.
  • Pontifax AgTech: Pontifax AgTech (now part of Pontifax Global Food and Agriculture Technology Fund) invests in food and agtech. Closely comparable to iSelect on stage (early/growth) and thesis (food/agriculture technology convergence).
  • Fall Line Capital: Fall Line Capital is an early-stage venture firm focused on agricultural technology. Direct peer to iSelect in agtech investing with comparable portfolio stage and sector focus.
  • Breakthrough Energy Ventures: Breakthrough Energy Ventures (Bill Gates–backed) invests in companies tackling climate change, with significant overlap in agriculture, food, and health technologies. Comparable to iSelect on early-stage climate-adjacent food/ag investing.

Broad incumbents

  • ADM Ventures: ADM Ventures is the corporate venture arm of Archer Daniels Midland, one of the world's largest food/ag companies. Larger incumbent operating broadly in iSelect's sector and an existing co-investor in iSelect's portfolio companies (e.g., Miraterra round).
  • Khosla Ventures: Khosla Ventures is a major US venture firm with significant early-stage exposure to food, agriculture, and health technology. Larger incumbent with broader portfolio but thematic overlap with iSelect's investment areas.
  • Leaps by Bayer: Leaps by Bayer is the corporate venture arm of Bayer focused on life sciences, agriculture, and health. Strategic incumbent that competes for food/ag/health deals and brings deep corporate balance sheet capacity versus iSelect's evergreen structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

iSelect Fund social profiles

Digital presence

iSelect Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iSelect Fund leadership team

Management profile

Number of profiles

Profiles12 records

iSelect Fund funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iSelect Fund M&A and investment

M&A and investment

M&A

Investments85 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iSelect Fund

What does iSelect Fund do?

iSelect Fund is an evergreen venture capital fund that provides accredited investors, family offices, wealth managers, and institutional investors access to vetted early-stage investment opportunities in food, agriculture, healthcare, and resource efficiency sectors. The fund conducts up to 120 hours of due diligence per portfolio company, manages investments on behalf of investors, and offers co-investment opportunities alongside top-tier venture capital firms. Securities are offered through North Capital Private Securities, a registered broker-dealer.

Is iSelect Fund a public or private company?

iSelect Fund is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was iSelect Fund founded?

iSelect Fund was founded in 2014. It employs 11 to 50 people.

Where is iSelect Fund based?

iSelect Fund is headquartered in St Louis, United States, in the North America region.

How does iSelect Fund make money?

One revenue line is on record: venture Fund Management.

Who are iSelect Fund's main competitors?

Direct peers on record are S2G Investments, Anterra Capital, Cultivian Sandbox Ventures, AgFunder, Pontifax AgTech, Fall Line Capital and Breakthrough Energy Ventures. Broad incumbents are ADM Ventures, Khosla Ventures and Leaps by Bayer.

Does iSelect Fund have an API?

No public API is recorded for iSelect Fund.

What industry is iSelect Fund in?

iSelect Fund's product category is Venture Capital and Impact Investing. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSAEAAAC, Portfolio Construction & Asset Allocation Advisory. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Vive Crop ProtectionVive Secures $10 Million in Oversubscribed Financing RoundVive Crop Protection has closed a $10 million USD oversubscribed investment round with participation from Emmertech, iSelect, BDC Capital, and Farm Credit Canada through its investment arm FCC Capital. The funding will support Vive's product pipeline advancement, market expansion across the United States and Canada, and scaling of its High-Velocity Commercialization Engine technology. FCC's investment is part of its broader $2-billion commitment to support Canadian agri-food and ag-tech innovation through 2030.BiolumicBioLumic Oversubscribed Funding Round Accelerates a New Category of Non-GMO Seed Traits — BIOLUMICBioLumic Inc. has announced the closure of its oversubscribed Series B Extension funding round, securing $8.3 million from investors including Ki Tua Fund, Azolla Ventures, and iSelect Fund to advance its new category of seed traits known as xTraits™. The funding will support the rollout of innovations that enhance seed traits, improving yield, stress resilience, and nutritional composition while dramatically reducing development time and costs. BioLumic aims to capture 10% of the non-transgenic seed trait market within five years through this breakthrough technology and its commercial partnerships.OurCrowdBioLumic oversubscribed funding round accelerates a new category of non-GMO seed traitsBioLumic Inc. closed an oversubscribed $8.3 million Series B Extension funding round led by Ki Tua Fund, Azolla Ventures, and iSelect Fund to accelerate the commercialization of its xTraits™ light-activated seed technology. The company has launched its first commercial activation system at Gro Alliance’s facility in the U.S., with field trials showing over 20% yield gains in hybrid corn for the 2026 planting season.YahooBioLumic Oversubscribed Funding Round Accelerates a New Category of Non-GMO Seed TraitsBioLumic closed an oversubscribed $8.3M Series B Extension from new and existing investors, including Ki Tua Fund, Azolla Ventures, and iSelect Fund. The capital will accelerate commercialization of its xTraits light-activated seed traits in corn, rice, soybean, and forage, with a goal of capturing 10% of the non-transgenic seed trait market within five years.PR Newswire APACHARPE BIOHERBICIDE SOLUTIONS SECURES $3 MILLION IN FINANCING ROUNDHarpe Bioherbicide Solutions has closed a financing round of more than $3 million, led by Alexandria Venture Investments and iSelect Fund Management. The capital will be used to advance research and development for its plant-based herbicide formulations and strengthen its intellectual property portfolio. Additionally, former U.S. Ambassador Kip E. Tom joined the company's Board of Directors.GlobeNewswirePattern Ag Announces Additional FundingPatternAg closed an additional funding round with investors including The Nature Conservancy, iSelect Fund, and LAUNCH. The funds will strengthen connections with soil health initiatives and enhance its soil health analytics offering. The company plans to make its analytics more actionable for growers.PR NewswireMolecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial AccessMolecular Assemblies, Inc. announced the close of a $24 million oversubscribed Series A financing round with participation from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, Argonautic Ventures, and LYFE Capital. The funding will advance the company's proprietary enzymatic DNA synthesis technology toward early commercialization, building on existing partnerships with Codexis and GE Research. The enzymatic approach aims to overcome limitations of traditional phosphoramidite chemistry by enabling cost-effective production of longer DNA sequences using aqueous, non-toxic reagents.AgFunderNewsCollaboration, Health and the Future Farmer: Key Lessons on the Future of AgCraig Herron, VP at iSelect Fund, outlined five key takeaways from a Davos on the Delta event in Memphis, covering supply chain transparency, new business models, and collaboration. He noted input markets are ripe for disruption and that the future farmer is an industry-wide concern. The industry still has much work to do on food and agriculture's role in health.FinSMEsEntac Medical Completes Series A2 Financing RoundEntac Medical completed its Series A2 financing round led by Innova, with participation from i-Select Fund and Sage Fund. The company will use the funds to complete development of PrevisEA, a noninvasive device that predicts postoperative ileus within 12 hours after surgery. Entac plans additional applications of the platform technology in gastrointestinal predictive medicine.TechCrunchAgrilyst raises another $1.5M for its intelligent indoor farming platformAgrilyst raised $1.5M from iSelect Fund, Argonautic Ventures, Horizons Lab, and Onlan Capital Fund, plus existing investors. The company added 100 customers in 2017 and grew revenue and customers 500% since 2016. It plans to use the funds for growth and new markets, including expansion into China.